Royce & Associates’s Kite Pharma, Inc. KITE Stock Holding History

Royce & Associates’s Portfolio KITE Stock Details KITE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-800	Closed	-$46K	–	1330
2014 Q4	$46K	Hold	800	–	–	﹤0.01%	1263
2014 Q3	$23K	Buy	+800	New	+$19.8K	﹤0.01%	1382

Other funds holding KITE

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

WCM

Wildcat Capital Management New York $229M AUM 132.65% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

SFM

Soros Fund Management New York $8.14B AUM 35.85% 1-Year Est. Return

Royce & Associates's KITE Position: Q1 2015 in Review

Royce & Associates sold out of Kite Pharma, Inc. (KITE) in Q1 2015, closing a stake of 800 shares — an estimated $46K sold.

Royce & Associates first reported a position in KITE in Q3 2014 and held it in 2 quarters. The position peaked at $46K in Q4 2014. 148 funds tracked by Wall St. Rank hold KITE as of Q1 2015.

Royce & Associates reported no remaining Kite Pharma, Inc. position as of Q1 2015 after selling out during the quarter.
Royce & Associates sold 800 Kite Pharma, Inc. shares in Q1 2015, an estimated $46K.
Royce & Associates first reported a position in Kite Pharma, Inc. in Q3 2014 and held it in 2 quarters.
Royce & Associates's Kite Pharma, Inc. position peaked at $46K in Q4 2014.
148 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q1 2015.

Based on Royce & Associates's 13F filing for Q1 2015, filed 13 May 2015.